Bart De Geest

3.7k total citations
98 papers, 3.0k citations indexed

About

Bart De Geest is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Bart De Geest has authored 98 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 36 papers in Cardiology and Cardiovascular Medicine and 32 papers in Surgery. Recurrent topics in Bart De Geest's work include Virus-based gene therapy research (18 papers), Cardiovascular Function and Risk Factors (18 papers) and Lipoproteins and Cardiovascular Health (11 papers). Bart De Geest is often cited by papers focused on Virus-based gene therapy research (18 papers), Cardiovascular Function and Risk Factors (18 papers) and Lipoproteins and Cardiovascular Health (11 papers). Bart De Geest collaborates with scholars based in Belgium, Netherlands and United States. Bart De Geest's co-authors include Frank Jacobs, Mudit Mishra, Sophie Van Linthout, Eline Van Craeyveld, Ilayaraja Muthuramu, Stephanie Gordts, Jan Snoeys, Désiré Collen, Paul Holvoet and Joke Lievens and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Bart De Geest

96 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart De Geest Belgium 35 1.3k 871 788 547 495 98 3.0k
Frank Jacobs Belgium 27 875 0.7× 594 0.7× 395 0.5× 227 0.4× 205 0.4× 62 2.2k
Sharon Page Germany 21 1.1k 0.8× 546 0.6× 548 0.7× 306 0.6× 106 0.2× 32 3.5k
Peter Ellinghaus Germany 28 1.6k 1.2× 519 0.6× 465 0.6× 153 0.3× 96 0.2× 74 3.1k
Torbjörn Egelrud Sweden 30 808 0.6× 321 0.4× 346 0.4× 205 0.4× 553 1.1× 43 3.6k
Yabing Chen United States 26 1.2k 0.9× 301 0.3× 250 0.3× 354 0.6× 135 0.3× 54 2.6k
Evelyn Orsó Germany 29 2.5k 1.9× 2.7k 3.1× 212 0.3× 187 0.3× 378 0.8× 62 5.0k
Christophe Blanquart France 26 1.6k 1.2× 584 0.7× 141 0.2× 141 0.3× 321 0.6× 80 2.9k
Noriyuki Koyama Japan 24 821 0.6× 350 0.4× 185 0.2× 148 0.3× 113 0.2× 64 2.1k
Hirohisa Tsujinoue Japan 25 1.1k 0.8× 282 0.3× 262 0.3× 354 0.6× 251 0.5× 50 2.6k
Felix Heymann Germany 31 1.1k 0.8× 638 0.7× 136 0.2× 282 0.5× 306 0.6× 54 5.3k

Countries citing papers authored by Bart De Geest

Since Specialization
Citations

This map shows the geographic impact of Bart De Geest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart De Geest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart De Geest more than expected).

Fields of papers citing papers by Bart De Geest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart De Geest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart De Geest. The network helps show where Bart De Geest may publish in the future.

Co-authorship network of co-authors of Bart De Geest

This figure shows the co-authorship network connecting the top 25 collaborators of Bart De Geest. A scholar is included among the top collaborators of Bart De Geest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart De Geest. Bart De Geest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geest, Bart De & Sophie Van Linthout. (2024). Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world. European Heart Journal. 45(39). 4216–4218. 1 indexed citations
2.
3.
4.
Geest, Bart De & Mudit Mishra. (2022). Impact of High-Density Lipoproteins on Sepsis. International Journal of Molecular Sciences. 23(21). 12965–12965. 20 indexed citations
5.
Geest, Bart De & Mudit Mishra. (2022). Role of Oxidative Stress in Diabetic Cardiomyopathy. Antioxidants. 11(4). 784–784. 97 indexed citations
6.
Geest, Bart De & Mudit Mishra. (2021). Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies. Biomedicines. 9(11). 1645–1645. 18 indexed citations
7.
Mishra, Mudit & Bart De Geest. (2020). High-Density Lipoprotein-Targeted Therapies for Heart Failure. Biomedicines. 8(12). 620–620. 8 indexed citations
8.
Loon, Elisabet Van, Joseph Pierre Aboumsallem, Evelyne Lerut, et al.. (2020). Mesangial matrix expansion in a novel mouse model of diabetic kidney disease associated with the metabolic syndrome. Journal of Nephropathology. 10(2). e17–e17. 1 indexed citations
9.
Aboumsallem, Joseph Pierre, Ilayaraja Muthuramu, Mudit Mishra, H.J.M. Kempen, & Bart De Geest. (2019). Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice. International Journal of Molecular Sciences. 20(6). 1273–1273. 32 indexed citations
10.
Aboumsallem, Joseph Pierre, Ilayaraja Muthuramu, Mudit Mishra, & Bart De Geest. (2019). Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice. International Journal of Molecular Sciences. 20(9). 2222–2222. 12 indexed citations
11.
Mishra, Mudit, Ilayaraja Muthuramu, Joseph Pierre Aboumsallem, H.J.M. Kempen, & Bart De Geest. (2018). Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice. International Journal of Molecular Sciences. 19(11). 3399–3399. 19 indexed citations
12.
Aboumsallem, Joseph Pierre, et al.. (2018). Successful treatment of established heart failure in mice with recombinant HDL (Milano). British Journal of Pharmacology. 175(21). 4167–4182. 26 indexed citations
13.
Gordts, Stephanie, Neha Singh, Ilayaraja Muthuramu, & Bart De Geest. (2014). Pleiotropic Effects of HDL: Towards New Therapeutic Areas for HDL-Targeted Interventions. Current Molecular Medicine. 14(4). 481–503. 21 indexed citations
14.
Jacobs, Frank, Leanne de Koning, Linh‐Chi Bui, et al.. (2013). Hepatocyte-specific Dyrk1a gene transfer rescues plasma apolipoprotein A-I levels and aortic Akt/GSK3 pathways in hyperhomocysteinemic mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1832(6). 718–728. 13 indexed citations
15.
Singh, Neha, Eline Van Craeyveld, Marc Tjwa, et al.. (2012). Circulating Apoptotic Endothelial Cells and Apoptotic Endothelial Microparticles Independently Predict the Presence of Cardiac Allograft Vasculopathy. Journal of the American College of Cardiology. 60(4). 324–331. 39 indexed citations
16.
Jacobs, Frank, Eline Van Craeyveld, Yingmei Feng, & Bart De Geest. (2009). The diameter of liver sinusoidal fenestrae is not a major determinant of lipoprotein levels and atherosclerosis in cholesterol-fed rabbits. Cardiovascular Pathology. 20(1). 44–50. 3 indexed citations
17.
Wisse, E., Frank Jacobs, Baki Topal, P.M. Frederik, & Bart De Geest. (2008). The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Therapy. 15(17). 1193–1199. 235 indexed citations
18.
Jacobs, Frank, Jan Snoeys, Yingmei Feng, et al.. (2008). Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer. Gene Therapy. 15(8). 594–603. 51 indexed citations
19.
Linthout, Sophie Van, Frank Spillmann, Anna Foryst‐Ludwig, et al.. (2007). Increased high density lipoprotein cholesterol induced by human apolipoprotein A-1 gene transfer increases adiponectin expression in abdominal adipose tissue. Circulation. 116(16). 286–286. 1 indexed citations
20.
Geest, Bart De, et al.. (1999). Promoter dependence of persistence of the effect of the human apo E enhancer on human apolipoprotein A-I expression after adenoviral gene transfer is partially explained by promoter attenuation. European Heart Journal. 20. 184. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Jacobs Breakdown of academic impact, for papers by Sharon Page Breakdown of academic impact, for papers by Peter Ellinghaus Breakdown of academic impact, for papers by Torbjörn Egelrud Breakdown of academic impact, for papers by Yabing Chen Breakdown of academic impact, for papers by Evelyn Orsó Breakdown of academic impact, for papers by Christophe Blanquart Breakdown of academic impact, for papers by Noriyuki Koyama Breakdown of academic impact, for papers by Hirohisa Tsujinoue Breakdown of academic impact, for papers by Felix Heymann
Rankless by CCL
2026